Last updated on January 2019

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Study Of The Efficacy And Safety Of tofacitinib In Subjects With Active Ankylosing Spondylitis (AS).


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: *Healthy Children Studies | Ankylosing spondylitis
  • Age: - 18 Years
  • Gender: Male or Female

 

Inclusion:

  • Diagnosis of Active Ankylosing Spondylitis (AS)
  • BASDAI Score of ≥4 & BASDAI Score of ≥4 on Question 2
  • Radiograph of SI joints documenting diagnosis of AS
  • Active disease despite IR/IT to at least two different oral NSAIDs
  • Can be on MTX ≤ 20mg.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.